About SRT Therapeutics
SRT Therapeutics is a private company based in San Diego, California, incorporated in 2024 in Delaware. It has reported $47,399,588 raised in one offering on Form D since August 2025. Its chief executive is Lauren Otsuki.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 2025 | Aug 14, 2025 | $47,399,588of $47.5M target | 55 | $861K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SRT Therapeutics's Form D filed Aug 14, 2025.
RB
BD
EP
Ed Prunchunas
Director
MW
Michael Walsh
Director
Also a president, secretary and chief financial officer, director at Evida Biosciences.
LO
Lauren Otsuki
President and Chief Executive Officer, director
Also a director at Evida Biosciences and an executive officer and director at GLO Pharma.
SW